Market Overview

The Global Animal Hormone Therapy Market was valued at USD 1,727.0 million in 2023 and is expected to reach USD 2,493.8 million by 2031 while growing at a CAGR of 4.7% during the forecast period (2024-2031).

 *Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Market Dynamics

This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global animal hormone therapy market growth. Animal hormone therapy in veterinary medicine enhances animal functions. Precision livestock farming, using techs like analytics and sensors, incorporates hormone therapies to optimize breeding and overall livestock productivity. Increasing consumer awareness drives demand for ethically and safely produced animal products, including those involving responsible hormone use.

The Animal Hormone Therapy market is poised for significant growth in the upcoming years, driven by the increasing demand for animal protein, technological advancements in hormone therapy, and a rising livestock population. Despite these favorable factors, the market's expansion could encounter hindrances, such as regulatory challenges intertwined with ethical concerns and resistance and safety issues.

Furthermore, the global animal hormone therapy industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.

Segmentation – By Application Analysis

The Global Animal Hormone Therapy Market is segmented among Growth Promotors, Performance Enhancers, and Other Applications, based on application. In 2023, Performance Enhancers accounted for the majority of the market share*.

 *Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Segmentation – By Animals Analysis

The Global Animal Hormone Therapy Market is segmented among Companion Animals and Livestock, based on animals. In 2023, Companion Animals accounted for the majority of the market share*.

 *Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Global Animal Hormone Therapy Market: Regional Analysis

Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031).

 *Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Competitive Landscape

Some of the key players operating in the market are Merck & Co. Inc., Zoetis Inc., Elanco (Bayer Animal Health), Boehringer Ingelheim, Bimeda Animal Health, Soparfin SCA (Vetiquinol), Virbac Group, CEVA Sante Animale, HIPRA Animal Health, and Syntex SA.

Table of Contents:

1. Research Methodology and Market Scope

• Research Methodology

• Market Scope

2. Executive Summary

3. Global Animal Hormone Therapy Market Dynamics

• Drivers

• Restraints

• Opportunity

4. Global Animal Hormone Therapy Industry Analysis

• PEST Analysis

• Porter's Five Force Analysis

• Recent Deals Analysis

5. Global Animal Hormone Therapy Market Segmentation, By Application

• Global Animal Hormone Therapy Market Share Analysis, By Application

• Global Animal Hormone Therapy Market Growth Analysis, By Application

• Global Animal Hormone Therapy Market Trends, By Application

o Growth Promotors

o Performance Enhancers

o Other Applications

6. Global Animal Hormone Therapy Market Segmentation, By Animals

• Global Animal Hormone Therapy Market Share Analysis, By Animals

• Global Animal Hormone Therapy Market Growth Analysis, By Animals

• Global Animal Hormone Therapy Market Trends, By Animals

o Companion Animals

o Livestock

7. Global Animal Hormone Therapy Market Segmentation, By Region

• Global Animal Hormone Therapy Market Share Analysis, By Region

• Global Animal Hormone Therapy Market Growth Analysis, By Region

• Global Animal Hormone Therapy Market Trends, By Region

o North America

o Europe

o Asia Pacific

o Latin America

o Middle East

o Africa

8. Competitive Landscape

• Merck & Co. Inc.*

o Company Overview

o Financial Performance

o Key Development/Strategies

o SWOT Analysis

• Zoetis Inc.

• Elanco (Bayer Animal Health)

• Boehringer Ingelheim

• Bimeda Animal Health

• Soparfin SCA (Vetiquinol)

• Virbac Group

• CEVA Sante Animale

• HIPRA Animal Health

• Syntex SA

 *Similar analysis will be provided for each company listed above.